Fumihiro Saika

Fumihiro Saika

Auto-generated profile, based on publicly available information

Fumihiro Saika

Department of Physiological Sciences School of Pharmaceutical Sciences, Wakayama Medical University Wakayama Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2024 in Glia
Verified
Journal Article
Open access
FSFumihiro Saika
Fumihiro Saika
YFYohji Fukazawa
Yohji Fukazawa
YHYu Hatano
Yu Hatano
SKShiroh Kishioka
Shiroh Kishioka
YHYuko Hino
Yuko Hino
NKNorikazu Kiguchi
Norikazu Kiguchi
It is well‐established that spinal microglia and peripheral macrophages play critical roles in the etiology of neuropathic pain; however, growing evidence suggests sex differences in pain hypersensitivity owing to microglia and macrophages. Therefore, it is crucial to understand sex‐ and androgen‐dependent characteristics of pain‐related myeloid cells in mice with nerve injury‐induced neuropathic pain. To deplete microglia and macrophages, pexidartinib (PLX3397), an inhibitor of the colony‐stimulating factor 1 receptor, was orally administered, and mice were subjected to partial sciatic nerve ligation (PSL). Following PSL induction, healthy male and female mice and male gonadectomized (GDX) mice exhibited similar levels of spinal microglial activation, peripheral macrophage accumulation, and mechanical allodynia. Treatment with PLX3397 significantly suppressed mechanical allodynia in normal males; this was not observed in female and GDX male mice. Sex‐ and androgen‐dependent differences in the PLX3397‐mediated preventive effects were observed on spinal microglia and dorsal root ganglia (DRG) macrophages, as well as in expression patterns of pain‐related inflammatory mediators in these cells. Conversely, no sex‐ or androgen‐dependent differences were detected in sciatic nerve macrophages, and inhibition of peripheral CC‐chemokine receptor 5 prevented neuropathic pain in both sexes. Collectively, these findings demonstrate the presence of considerable sex‐ and androgen‐dependent differences in the etiology of neuropathic pain in spinal microglia and DRG macrophages but not in sciatic nerve macrophages. Given that the mechanisms of neuropathic pain may differ among experimental models and clinical conditions, accumulating several lines of evidence is crucial to comprehensively clarifying the sex‐dependent regulatory mechanisms of pain.

1 January 2020 in Proceedings for Annual Meeting of The Japanese Pharmacological Society
Verified
Journal Article
Open access
PDF file
FSFumihiro Saika
Fumihiro Saika
NKNorikazu Kiguchi
Norikazu Kiguchi
DKDaichi Kobayashi
Daichi Kobayashi
YIYuya Ideguchi
Yuya Ideguchi
SMShinsuke Matsuzaki
Shinsuke Matsuzaki
SKShiroh Kishioka
Shiroh Kishioka
Chronic neuroinflammation plays an important role in the molecular basis of neuropathic pain. It has been widely accepted that the various immune cells contribute to the development of neuropathic pain. Among immune cells, the role of macrophages and microglia has been well demonstrated. In this study, we evaluated the effects of macrophages/microglia on neuropathic pain using mice that can induce Gi-Designer Receptors Exclusively Activated by Designer Drugs(Gi-DREADD)driven by macrophages/microglia-specific cx3cr1 promoter (CX3CR1-hM4Di). Neuropathic pain model mice were generated by partial sciatic nerve ligation (PSL) or anti-cancer drugs, and mechanical allodynia was evaluated using von Frey test. In CX3CR1-hM4Di mice after PSL, expression of hM4Di was localized in both F4/80 positive macrophages and Iba1 positive microglia. Intraperitoneal or intrathecal administration of clozapine-N-oxide (CNO), a ligand for hM4Di, attenuated mechanical allodynia in male CX3CR1-hM4Di mice after PSL or repeated administration of anticancer drugs. In addition, these anti-allodynic effects was observed in male, but not in female mice. These results support the notion that sex-dependent roles of macrophage/microglia in neuropathic pain and the pharmacological inhibition of these cells might be effective therapeutics for neuropathic pain.